These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17070308)

  • 1. Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines.
    Pandha H; Birchall L; Meyer B; Wilson N; Relph K; Anderson C; Harrington K
    J Urol; 2006 Nov; 176(5):2255-61. PubMed ID: 17070308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model.
    Soltau J; Zirrgiebel U; Esser N; Schächtele C; Totzke F; Unger C; Merfort I; Drevs J
    Anticancer Res; 2008; 28(2A):933-41. PubMed ID: 18507039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
    Ullen A; Schwarz S; Lennartsson L; Kalkner KM; Sandstrom P; Costa F; Lennernas B; Linder S; Nilsson S
    Scand J Urol Nephrol; 2009; 43(2):98-103. PubMed ID: 19101859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
    Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ
    Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.
    Montague R; Hart CA; George NJ; Ramani VA; Brown MD; Clarke NW
    Eur Urol; 2004 Sep; 46(3):389-401; discussion 401-2. PubMed ID: 15306113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo.
    Yuasa T; Nogawa M; Kimura S; Yokota A; Sato K; Segawa H; Kuroda J; Maekawa T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):853-9. PubMed ID: 15701876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.
    Romani AA; Desenzani S; Morganti MM; La Monica S; Borghetti AF; Soliani P
    Biochem Pharmacol; 2009 Jul; 78(2):133-41. PubMed ID: 19464430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Aug; 180(2):729-36. PubMed ID: 18555493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin.
    Jin X; Wu XX; Abdel-Muneem Nouh MA; Kakehi Y
    J Urol; 2007 May; 177(5):1894-9. PubMed ID: 17437844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.
    Coxon JP; Oades GM; Kirby RS; Colston KW
    BJU Int; 2004 Jul; 94(1):164-70. PubMed ID: 15217454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New research findings on zoledronic acid: survival, pain, and anti-tumour effects.
    Saad F
    Cancer Treat Rev; 2008 Apr; 34(2):183-92. PubMed ID: 18061356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
    Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer properties of zoledronic acid.
    Green J; Lipton A
    Cancer Invest; 2010 Nov; 28(9):944-57. PubMed ID: 20879838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour activity of zoledronic acid.
    Clézardin P
    Cancer Treat Rev; 2005; 31 Suppl 3():1-8. PubMed ID: 16225995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
    Kijima T; Fujii Y; Suyama T; Okubo Y; Yonese J; Fukui I
    Int J Urol; 2008 Jun; 15(6):546-7. PubMed ID: 18489646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.